v-erbA Oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor

Cell Growth and Differentiation

Volumn 7, Issue 3, 1996, Pages 373-382

  Llanos, Susana ^a   Iglesias, Teresa ^a   Riese, Hans H ^b   Garrido, Teresa ^b   Caelles, Carme ^a   Muñoz, Alberto ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b Research Center   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL SUSPENSION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE INDUCTION; GLIA CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ANIMALS; BLOOD; CELL ADHESION; CELL COUNT; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; COLLAGENASES; FIBROBLAST GROWTH FACTOR 2; GENES, ERBA; GENES, JUN; MICE; NEOPLASM INVASIVENESS; NEUROGLIA; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, THYROID HORMONE; RNA, MESSENGER; TRIIODOTHYRONINE;

ANIMALIA;

EID: 0029805275     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Beug, H., and Vennström, B. Avian erythroleukemia: possible mechanisms involved in v-erbA oncogene function. In: M. D. Parker (ed.), Nuclear Hormone Receptors, pp. 355-375. London: Academic Press, 1991.
2. Graf, T., and Beug, H. Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation. Cell, 34: 7-9, 1983.
3. Frykberg, L., Palmieri, S., Beug, H., Graf, T., Hayman, M. J., and Vennström, B. Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes. Cell, 32: 227-238, 1983.
4. Fuerstenberg, S., Leitner, I., Schroeder, C., Schwartz, H., Vennström, B., and Beug, H. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukemic phenotype. EMBO J., 11: 3355-3366, 1992.
5. Pain, B., Melet, F., Pain, S. J., Flickinger, T., Raines, M., Peyrol, S., Moscovici, C., Moscovici, M G., Kung, H-J., Jurdic, P., Lazarides, E., and Samarut, J. EGF-R as a hemopoietic growth factor receptor. the c-erbB product is present in erythrocytic cells. Cell, 65: 37-46, 1991.
6. Kahn, P , Frykberg, L., Brady, G., Stanley, I. J., Beug, H., Vennström, B., and Graf, T. v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation. Cell, 100: 349-356, 1986.
7. Metz, T., and Graf, T. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia. Oncogene, 7: 597-605, 1992
8. Gandrillon, O., Jurdic, P., Pain, B., Desbois, C., Madjar, J. J., Moscovici, M. G., Moscovici, C., and Samarut, J. Expression of the v-erbA product, an altered nuclear hormone receptor is sufficient to transform erythrocytic cells in vitro. Cell, 58: 115-121, 1989.
9. Gandrillon, O., Jurdic, P., Benchaibi, M., Xiao, J-H., Ghysdael, J., and Samarut, J Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. Cell, 49: 687-697, 1987.
10. Sap, J., Muñoz, A., Damm, K., Goldberg, Y., Ghysdael, J., Leutz, A., Beug, H., and Vennström, B. The c-erbA protein is a high affinity receptor for thyroid hormone. Nature (Lond.), 324: 635-640, 1986.
11. Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., and Evans, R. M. The c-erbA encodes a thyroid hormone receptor Nature (Lond.), 324: 641-646, 1986.
12. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
13. Glass, C. K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocrinol. Rev., 15: 391-407, 1994.
14. Muñoz, A., Zenke, M., Gehring, U., Sap, J., Beug, H., and Vennström, B. Characterization of the hormone-binding domain of the chicken c-erbA/thyroid hormone receptor protein. EMBO J., 7: 155-159, 1988.
15. Sap, J., Muñoz, A., Schmitt, J., Stunnenberg, H., and Vennström, B. Repression of transcription mediated at a thyroid hormone response element by the v-erbA oncogene product. Nature (Lond.), 340: 242-244, 1989.
16. Bonde, B. G., and Privalsky, M. L. Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus. J. Virol., 64: 1314-1320, 1990
17. Nelson, C. C., Hendy, S. C., Faris, J. S., and Romaniuk, P. J. The effects of P-box substitutions in thyroid hormone receptor on DNA binding specificity. Mol Endocrinol , 8: 829-840, 1994.
18. Zenke, M., Muñoz, A., Sap, J., Vennström, B., and Beug, H. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell, 61: 1035-1049, 1990.
19. Barettino, D., Bugge, T. H., Bartunek, P., Vivanco Ruiz, M. d. M., Sonntag-Buck, V , Beug, H., Zenke, M., and Stunnenberg, H. G. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. EMBO J., 12: 1343-1354, 1993
20. Barettino, D., Vivanco Ruiz, M. d. M., and Stunnenberg, H G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J , 13: 3039-3049, 1994.
21. Damm, K., Thompson, C. C., and Evans, R. M. Protein encoded by the v-erbA functions as a thyroid-hormone receptor antagonist. Nature (Lond.), 339: 593-597, 1989
22. Sharif, M., and Privalsky, M. L. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell, 66: 885-893, 1991.
23. Chen, H , Smit-McBride, Z., Lewis, S., Sharif, M., and Privalsky, M. L. Nuclear hormone receptors involved in neoplasia: erbA exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain. Mol. Cell. Biol., 13: 2366-2376, 1993.
24. Schroeder, C., Gibson, L., and Beug, H. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand activated endogenous c-erbA and retinoic acid receptor. Oncogene, 7: 203-216, 1992.
25. Muñoz, A., Wrighton, C., Seliger, B., Bernal, J., and Beug, H Thyroid hormone receptor/c-erbA: control of commitment and differentiation in the neuronal/chromaffin progenitor line PC12. J. Cell Biol, 121: 423-438, 1993.
26. 3 independent, cell-specific manner Oncogene, 9: 2197-2206, 1994.
27. Garrido, C., Li, R. P., Samarut, J., Gospodarowicz, D., and Saule, S. v-erbA cooperates with bFGF in neuroretina cell transformation. Virology, 192: 578-586, 1993.
28. Barlow, C., Meister, B., Lardelli, M., Lendahl, and Vennström, B. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO J., 13: 4241-4250, 1994.
29. Iglesias, T., Llanos, S., López-Barahona, M., Pérez-Aranda, A., Rodríguez-Peña, A., Bernai, J., Höhne, A, Seliger, B., and Muñoz, A. c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line. Cell Growth & Differ., 5: 697-704, 1994.
30. Iglesias, T, Llanos, S., López-Barahona, M., Seliger, B., Rodríguez-Peña, A., Bernai, J., and Muñoz, A. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in a glial precursor cell line. Oncogene, 10: 1103-1110, 1995.
31. Gould, E., Frankfurt, M., Westlind-Danielson, A., and McEwen, B. Developing brain astrocytes are sensitive to thyroid hormone. Glia, 3: 283-292, 1990.
32. Huang, J. S., Huang, S. S., and Deuel, T. F. Transforming protein of simian sarcoma virus stimulates autocnne cell growth of SSV-transformed cells through platelet-derived growth factor cell surface receptors. Cell, 39: 79-87, 1984.
33. Lens, P. F., Altena, B., and Nusse, R. Expression of c-sis and platelet-derived growth factor in in vitro-transformed glioma cells from rat brain tissue transplancentally treated with ethylnitrosourea. Mol. Cell. Biol., 6: 3537-3540, 1986.
34. Beckmann, M. P., Betsholtz, C., Heldin, C-H., Westermark, B., Di Marco, E., Di Fiore, P. P., Robbins, K. C., and Aaronson, S. A. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science (Washington DC), 241: 1346-1349, 1988.
35. Hermanson, M., Funa, K., Hartman, M., Claesson-Welsch, L., Heldin, C-H., Westermark, B., and Nistér, M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops Cancer Res., 52: 3213-3219, 1992.
36. Wennström, S., Siegbahn, A., Yokote, K., Arvidsson, A-K., Heldin, C-H., Mon, S., and Claesson-Welsch, L. Membrane ruffling and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene, 9: 651-660, 1994.
37. Fleming, T. P , Matsui, T., Heidaran, M. A , Molloy, C. J., Artrip, J., and Aaronson, S. A. Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human cell proliferation in vitro. Oncogene, 7: 1355-1359, 1992.
38. Strawn, L. M., Mann, E., Elliger, S S , Chu, L. M , Germain, L. L., Niederfellner, G., Ullrich, A., and Shawver, L. K Inhibition of glioma cell growth by a truncated platelet-derived growth factor-β receptor. J. Biol. Chem., 269: 21215-21222, 1994.
39. Fleming, T. P., Matsui, T., Molloy, C. J., Robbins, K. C., and Aaronson, S. Autocnne mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. Proc. Natl. Acad. Sci USA, 86: 8063-8067, 1989.
40. Bejcek, B. E., Hoffman, R. M., Lipps, D., Li, D., Mitchell, C. A., Majerus, P. W., and Deuel, T. F. The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF α and β receptors intracellularly and initiate cellular transformation. J. Biol. Chem., 267: 3289-3293, 1992.
41. Lee, B. A., and Donoghue, D. J. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction J. Cell. Biol , 118: 1057-1070, 1992.
42. Desbois, C., Aubert, D., Legrand, C., Pain, B., and Samarut, J. A novel mechanism of action for v-erbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell, 67: 731-740, 1991.
43. Desbois, C., Pain, B., Guilhot, M., Benchaibi, M., Ffrench, J., Ghysdael, J., Madjar, J-J., and Samarut, J. v-erbA oncogene abrogates growth inhibition of chicken embryo fibroblasts induced by retinoic acid. Oncogene, 6: 2129-2135, 1991.
44. Schütte, J., Minna, J D , and Birrer, M. J. Deregulated expression of human c-jun transforms primary rat embryo fibroblasts in cooperation with an activaed c-Ha-ras gene and transforms Rat-1a cells as a single gene. Proc. Natl. Acad Sci. USA, 86: 2257-2261, 1989.
45. Bergers, G., Graninger, P., Braselmann, S., Wrighton, C., and Busslinger, M. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol., 15: 3748-3758, 1995.
46. Khazaie, K., Panayotou, G., Aguzzi, A , Samarut, J., Gazzolo, L., and Jurdic, P. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene. Oncogene, 6: 21-28, 1991.
47. Gandrillon, O., Ferrand, N., Michaille, J. J., Roze, L., Zile, M. H., and Samarut, J. c-erbA α/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. Oncogene, 9: 749-758, 1994.
48. Glineur, C., Zenke, M., Beug, H., and Ghysdael, J. Phosphorylation of the v-erbA protein is required for its function as an oncogene. Genes & Dev., 4: 1663-1676, 1990.
49. Beug, H., Mülner, E. W., and Hayman, M. J. Insights into erythroid differentiation obtained from studies on avian erythroblastosis virus. Curr. Opin. Cell. Biol., 6: 816-824, 1994.
50. Kundra, V., Soker, S., and Zetter, B. R. Excess early signalling activity inhibits cellular chemotaxis toward PDGF BB. Oncogene, 9: 1429-1435, 1994.
51. Bottenstein, J. E., and Sato, G. H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA, 76: 514-517, 1979.
52. Albini, A., Iwamoto, Y., Kleinman, H K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
53. Fidler, I. J. Selection of successive tumour lines for metastasis. Nature (New Biol.), 242: 148-149, 1973.
54. López-Barahona, M., Fialka, I., González-Sancho, J. M., Asunción, M., González, M., Iglesias, T., Bernai, J., Beug, H., and Muñoz, A. Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J., 14: 1145-1155, 1995.
55. Vennström, B., and Bishop, J. M. Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus. Cell, 28: 135-143, 1982.
56. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 7.43-7.50, 1989.
57. Feinberg, P. A , and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137: 266-267, 1983.
58. Church, G. M., and Gilbert, W. Genome sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.